expected on 9th bordeaux pharmacoepi festival may, 2020 ...- quality management system certificated...

2
Bordeaux PharmacoEpi Research Platform in Pharmacoepidemiology Meet our Team Members Bordeaux PharmacoEpi Permanent team of > 40 staff Transparency and Quality - Respect of the ENCePP code of conduct - Quality Management System certificated ISO 9001 : 2015 > 30 field studies: 50 to 46 000 patients > 50 studies using national health insurance system databases > 100 publications for the past 5 years Meet also the team at their booth! The first European on-line training program, more information on https://www.eu2p.org Don’t forget the 9 th Bordeaux PharmacoEpi Festival, expected on May, 2020 Over three days, six world-class experts will come to Bordeaux to talk of the topic of their choice. Good Science, good Wine, good Fun! More information soon on http://bordeauxpharmacoepi.eu/bpe-festival/ Cécile DROZ-PERROTEAU Director Nicholas MOORE President, FISPE Patrick BLIN Chief scientific officer Nicolas THURIN Scientific officer Régis LASSALLE Chief of Biostatistics and Data management Follow us on website or social network http://bordeauxpharmacoepi.eu @BxPharmacoEpi

Upload: others

Post on 10-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: expected on 9th Bordeaux PharmacoEpi Festival May, 2020 ...- Quality Management System certificated ISO 9001 : 2015 • > 30 field studies: 50 to 46 000 patients • > 50 studies using

Bordeaux PharmacoEpi Research Platform in Pharmacoepidemiology

Meet our Team Members

Bordeaux PharmacoEpi •  Permanent team of > 40 staff •  Transparency and Quality

- Respect of the ENCePP code of conduct - Quality Management System certificated ISO 9001 : 2015

•  > 30 field studies: 50 to 46 000 patients •  > 50 studies using national health insurance system

databases •  > 100 publications for the past 5 years

Meet also the team at their booth!

The first European on-line training program, more information on https://www.eu2p.org

Don’t forget the 9th Bordeaux PharmacoEpi Festival, expected on May, 2020

Over three days, six world-class experts will come to Bordeaux to talk of the topic of their choice.

Good Science, good Wine, good Fun!

More information soon on http://bordeauxpharmacoepi.eu/bpe-festival/

Cécile DROZ-PERROTEAU Director

Nicholas MOORE President, FISPE

Patrick BLIN Chief scientific officer

Nicolas THURIN Scientific officer

Régis LASSALLE Chief of Biostatistics and

Data management

Follow us on website or social network http://bordeauxpharmacoepi.eu

@BxPharmacoEpi

Page 2: expected on 9th Bordeaux PharmacoEpi Festival May, 2020 ...- Quality Management System certificated ISO 9001 : 2015 • > 30 field studies: 50 to 46 000 patients • > 50 studies using

Monday, August 26, 2019

(XXX/XXX): Publication Number / Poster Number

Antibiotic Exposure Prior to Hospital Admission for Acute Liver Injury. (1194/263) A. Grolleau, S. Duret, N. Thurin, M. Duong, R. Lassalle, P. Blin, C. Droz-Perroteau, SE. Gulmez, N. Moore

Antidepressant and Anxiolytic-Hypnotic Exposure Prior to Hospital Admission for Acute Liver Injury. (1195/264) A. Grolleau, S. Duret, N. Thurin, M. Duong, R. Lassalle, P. Blin, C. Droz-Perroteau, SE. Gulmez, N. Moore

Description of Treatment Resistant Depression in France, from The French Nationwide Claims Database. (204/83) P. Bosco-Lévy, A. Grelaud, P. Blin, B. Astruc, B. Falissard, P-M. Llorca, D. Schaetz, M-A. Bernard, R. Lassalle, N. Moore, C. Droz-Perroteau

NSAIDs and Analgesics Exposures Prior to Hospital Admission for Acute Liver Injury. (1201/270) A. Grolleau, S. Duret, N. Thurin, M. Duong, R. Lassalle, P. Blin, C. Droz-Perroteau, SE. Gulmez, N. Moore

Validation of a Complex Algorithm for the Diagnosis of Metastatic Castration-Resistant Prostate Cancer within a Claims Database. (333/212) N. Thurin, M. Rouyer, M. Gross-Goupil, M. Soulié, M. Roumiguié, S. Le Moulec, L. De Beaucoudrey, S. Lamarque, E. Bignon, J. Jové, C. Droz-Perroteau, N. Moore, Patrick Blin

Wednesday, August 28, 2019

Oral Presentation* Room 201 B

Empirical Assessment of Case-Based Methods for the Identification of Drug-Related Health Outcome of Interest in the French Nationwide Healthcare Database (SNDS). (830) N. Thurin, R. Lassalle, P. Blin, M. Pénichon, M. Schuemie, J. J Gagne, J. A Rassen, J. Benichou, A. Weill, C. Droz-Perroteau, N. Moore

Hall A

Salt-II: Study of Acute Liver Transplantation in France on 2008-2013. (194/73) S. Lignot-Maleyran, SE. Gulmez, S. Micon, R. Lassalle, J. Jové, C. Droz-Perroteau, N. Moore

Main Drug Classes Dispensed Prior to Hospital Admission for Acute Liver Injury. (1193/262) A. Grolleau, S. Duret, N. Thurin, M. Duong, R. Lassalle, P. Blin, C. Droz-Perroteau, SE. Gulmez, N. Moore

Poster Hall A Poster

Pharmacological Treatment Patterns in Heart Failure: A Population Based Cohort Study. (290/169) P. Bosco-Lévy, C. Favary, J. Jové, R. Lassalle, N. Moore, C. Droz-Perroteau

Revolutionary Study Designs - Nicolas Thurin (08:45am)

Pharmacovigilance - Gastrointestinal and Liver Burden of Disease - Gastrointestinal and Liver

Drug Utilization - Cardiovascular

Methods - Validation Studies

Burden of Disease – Nervous System

Hall A Poster

Challenges in Conducting a Multinational European Study of Severe Hypersensitivity Reactions among Recipients of Intravenous Iron. (640/109) L. Gutierrez, P. Blin, J. Dress, C. Droz-Perroteau, V. Ehrenstein, M. Forstner, C. Franzoni, R. Lassalle, M. Linder, N. Moore, I. Odsbu, J. Overbeek, S. Perez-Gutthann, FE. Pisa, K. Rascher, L. Rasouliyan, J. Reinold, KJ. Rothman, N. Saigi-Morgui, M. Schaller, L. Smits, A. Timmer, G. Toft, G. von Gersdorff, J. Fortuny

Methods - Study Design, Bias, and Confounding

Bordeaux PharmacoEpi – Plateforme de recherche en Pharmaco-épidémiologie CIC Bordeaux CIC1401 – INSERM – Université de BORDEAUX – CHU de Bordeaux – Adera

Bâtiment Le Tondu – case 41 – 146 rue Léo Saignat – 33076 Bordeaux cedex – FRANCE

Posters and Oral presentation* also downloadable on https://www.bordeauxpharmacoepi.eu/congres/ICPE_2019

* Downloadable after the oral presentation

Tuesday, August 27, 2019

Incidence of Direct Oral Anticoagulation Use for Non Valvular Atrial Fibrillation and Characteristics of Users in Six European Countries (2008-2015): A Cross-National Drug Utilization Study. (820) L. Ibanez, Mònica Sabate ́, X. Vidal, E. Ballarín, M. Rottenkolber, S. Schmiedl, A. Heeke, C. Huerta, E. Martin Merino, D. Montero, L. M Leon-Muñoz, C. Gasse, N. Moore, C. Droz-Perroteau, R. Lassalle, M. Aakjaer, M. Andersen, ML. De Bruin, R. Groenwold, R. Van den Ham, P. Souverein, O. Klungel, H. Gardarsdottir

Around the World with DUR - (09:15am) Ballroom B Collabora

tive

work

Collabora

tive

work